Identification of Therapeutic Targets in Metastatic Gastric Cancer

This is a pilot study aiming at identifying novel therapeutic molecular targets in patients with gastric cancer with lymph nodes or distant metastasis. All patients who are diagnosed with gastric cancer with metastases in the Prince of Wales Hospital will be screened for eligibility.

NCT Number	NCT07551440
Lead Sponsor	Chinese University of Hong Kong
Conditions	Stomach Neoplasms, Benign
Enrollment	100 participants
Start Date	2023-10-15
Primary Completion	2033-04 (estimated)
Study Completion	2033-10 (estimated)
Updated on ClinicalTrials.gov	2026-04-24